You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 236 No. 8, August 23, 1976 TABLE OF CONTENTS
  JAMA
  •  Online Features
  CLINICAL NOTES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (23)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Increased Erythrocytic Osmotic Fragility in Pseudohypertrophic Muscular Dystrophy

Edwin R. Fisher, MD; Emmanuel Silvestri; John W. Vester, MD; Sean Nolan, MD; Usman Ahmad, MD; Thaddeus S. Danowski, MD

JAMA. 1976;236(8):955.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE DEMONSTRATION by scanning electron microscopy1 that erythrocytes in patients with pseudohypertrophic muscular dystrophy (PHMD) have an irregular, crenated-like surface prompted us to investigate the fragility of these erythrocytes, since crenation represents an early stage in the development of osmotic fragility.2 Our studies indicate that the susceptibility of erythrocytes to hemolysis in hypotonic saline is increased in 85% of patients with PHMD.

Materials and Methods

Venous blood (0.1 ml) from 94 patients with PHMD and 19 healthy, aging, and sex-matched controls was added to hypotonic saline for the detection of osmotic fragility of erythrocytes. The concentrations of saline are indicated in the Table. The percent of hemolysis of erythrocytes was determined by spectrophotometry.

The diagnosis of PHMD was based in each instance on muscle weakness on recording ergometry, increased calf size, and increased serum creatine phosphokinase levels. In addition, electromyography (41 patients), motor nerve conduction velocity (40 patients), . . . [Full Text PDF of this Article]


Author Affiliations

From the departments of pathology (Dr Fisher and Mr Silvestri) and medicine (Drs Vester, Nolan, Ahmad, and Danowski), Shadyside Hospital, Pittsburgh.


Footnotes

Reprint requests to Director of Laboratories, Shadyside Hospital, 5230 Centre Ave, Pittsburgh, PA 15232 (Dr Fisher).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.